ArticleAmerican journal of translational research2025
Electroacupuncture attenuated cerebral ischemia injury correlated with increased glucose consumption and elevated hippocampal GLUT1/3 expression.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Acupuncture for Post-Stroke Cognitive Impairment: Mechanisms and Clinical Evidence (2020-2025).Neuropsychiatric disease and treatment · 2026Review
- A novel m7G RNA methylation-related signature associated with MAPK signaling pathways in acute ischemic stroke.PloS one · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesCerebral ischemic stroke (IS) is a prevalent cerebrovascular accident that can lead to severe consequences. Electroacupuncture (EA) has demonstrated efficacy in alleviating cerebral ischemia/reperfusion (I/R) injury; however, the underlying molecular mechanisms remain poorly understood. It has been reported that the upregulation of glucose transporter gene expressions restores the ability of cerebral cells to consume energy during I/R. However, whether the use of EA affects glucose metabolism remains elusive. This study tries to elucidate the role of EA in regulating glucose metabolism during cerebral I/R process.
methodsRats with middle cerebral artery occlusion (MCAO) were employed as cerebral I/R injury models, and EA were performed at Baihui and Shenting acupoints in the modeled rats as treatment strategies. Additionally, Magnetic Resonance Imaging (MRI) was employed to measure cerebral infarction volume, Positron Emission Tomography/Computed Tomography (PET/CT) to evaluate glucose uptake in the hippocampus, neurological deficit scoring along with Morris Water Maze (MWM) testing was used to assess neurological deficits, and Western blot and Enzyme-linked Immunosorbent Assay (ELISA) tests determined the expression levels of glucose transporters genes GLUT1 and GLUT3.
resultsNeurological deficit scoring and MWM test results indicated that EA at Baihui and Shenting acupoints significantly alleviated neurological deficits caused by I/R injury. MRI results also showed that the treatment reduced the cerebral infarction volume. Moreover, PET/CT outcome revealed that EA at the two acupoints enhanced glucose uptake and metabolism in the injured cerebral hippocampus. At the molecular level, EA at the two acupoints significantly upregulated the expression of glucose transporter genes GLUT1 and GLUT3, as evidenced by Western blot results.
conclusionsEA at Baihui and Shenting acupoints can ameliorate I/R injury and facilitate glucose uptake and metabolism by promoting the expression of hippocampal glucose transporter genes GLUT1 and GLUT3.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.